Chemical Component Summary

Name3,3'-(2,4-diaminopteridine-6,7-diyl)diphenol
Identifiers3-[2,4-bis(azanyl)-7-(3-hydroxyphenyl)pteridin-6-yl]phenol
FormulaC18 H14 N6 O2
Molecular Weight346.343
TypeNON-POLYMER
Isomeric SMILESc1cc(cc(c1)O)c2c(nc3c(n2)c(nc(n3)N)N)c4cccc(c4)O
InChIInChI=1S/C18H14N6O2/c19-16-15-17(24-18(20)23-16)22-14(10-4-2-6-12(26)8-10)13(21-15)9-3-1-5-11(25)7-9/h1-8,25-26H,(H4,19,20,22,23,24)
InChIKeyUJIAQDJKSXQLIT-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count40
Chiral Atom Count0
Bond Count43
Aromatic Bond Count23

Drug Info: DrugBank

DrugBank IDDB05552 
NameTG100-115
Groups investigational
DescriptionAn NSAID that inhibits PI-3K gamma and delta.
Synonyms
  • 3-(2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl)phenol
  • 6,7-Bis(3-hydroxyphenyl)pteridine-2,4-diamine
  • TG100-115
IndicationInvestigated for use/treatment in angioedema and myocardial infarction.
Categories
  • Benzene Derivatives
  • Heterocyclic Compounds, Fused-Ring
  • Phosphatidylinositol 3-Kinases, antagonists & inhibitors
CAS number677297-51-7

Drug Targets

NameTarget SequencePharmacological ActionActions
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformMPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLW...unknowninhibitor
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoformMELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRK...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL230011
PubChem 10427712
ChEMBL CHEMBL230011
ChEBI CHEBI:94691